Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
doi:10.1016/S0140-6736(18)31773-2 34
Medication review is essential
[1] [5] The Medicines and Healthcare products Regulatory Agency (MHRA) has approved it specifically for glycaemic control in adults with type 2 diabetes, often in combination with other glucose-lowering medications or as monotherapy when metformin is not tolerated
This individualized approach is more effective than empiric supplementation and avoids unnecessary or potentially harmful products
US$ 21.41
US$ 23.16
US$ 28.38
US$ 28.26
